(Q45057645)

9 December 2017

Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes (English)

1 reference

9 December 2017

0 references

heart rate variability

0 references

0 references

4

1 reference

9 December 2017

J I Davies

1

1 reference

9 December 2017

M Band

series ordinal

2

1 reference

9 December 2017

A Morris

series ordinal

3

1 reference

9 December 2017

9 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

47

1 reference

9 December 2017

10

1 reference

9 December 2017

1687-1694

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1510-8

9 December 2017

0 references

cites work

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

1 reference

12 December 2020

Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

12 December 2020

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

1 reference

12 December 2020

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

1 reference

12 December 2020

Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

1 reference

12 December 2020

Improved endothelial function with metformin in type 2 diabetes mellitus

1 reference

12 December 2020

Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans

1 reference

12 December 2020

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1 reference

12 December 2020

Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement

1 reference

12 December 2020

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Measurement of plasma angiotensin II

1 reference

12 December 2020

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

12 December 2020

Aspirin improves endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

1 reference

12 December 2020

Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

1 reference

12 December 2020

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

1 reference

12 December 2020

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

12 December 2020

Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

1 reference

12 December 2020

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

12 December 2020

Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus

1 reference

12 December 2020

The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus

1 reference

12 December 2020

Prognostic value of coronary vascular endothelial dysfunction

1 reference

12 December 2020

Nitric oxide and cardiac autonomic control in humans

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00125-004-1510-8

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference